A Study of ASP1012 in Adults With Solid Tumors
Clinical trial NCT06171178 · TERMINATED
Trial details
- NCT number
- NCT06171178
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2025-09-11
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.